Total Funding
24
50
Total FundingVenture - Series Unknown raised
Growth Score 24 in past quarter
-3 pts
Heat Score 50 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
70243
Nortis is developing the next generation of invitro systems that will allow scientists to better understand the causes of human diseases.
- Alan Nelson: Founder and Chairman
- Thomas Neumann: Chief Scientific OfficerPast Role: Nortis, President and CEO
About the Company
Nortis is a biotech company that has developed tissue-engineering techniques and organ-on-a-chip systems for the creation of a human micro-tissue environment within small, disposable, microfluidic chips. The company's technology enables living models of human organs that will drastically accelerate the discovery and introduction of new
therapies and alleviate the use of lab animals. By growing tissue from human organ systems inside small microfluidic chips, researchers and assay developers can conduct in-vitro testing directly on functional human tissues.
Nortis was founded in 2012 and is headquartered in Woodinville, Washington.
